Lista de obras -

A polygenic risk score for multiple myeloma risk prediction

artículo científico publicado en 2022

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

artículo científico publicado en 2017

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

artículo científico publicado en 2016

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

artículo científico publicado en 2011

Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)

scientific article published on 29 October 2019

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

artículo científico publicado en 2021

Genetically determined telomere length and multiple myeloma risk and outcome

artículo científico publicado en 2021

High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.

artículo científico publicado en 2019

Identification of miRSNPs associated with the risk of multiple myeloma.

artículo científico publicado en 2016

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

artículo científico publicado en 2018

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

scientific article published on 22 July 2018

Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis

scientific article published on 06 February 2019

Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis

scientific article published on 12 November 2019

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?

artículo científico publicado en 2020

The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis